Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

BMS scientists prepare novel HIV reverse transcriptase inhibitors

Sep. 1, 2003

In vitro anti-HIV-1 activity of leflunomide reported by U. of Zurich researchers

Aug. 29, 2003

Topical TMC-120, a NNRTI, inhibits vaginal transmission of HIV-1 in hu-SCID mice

Aug. 29, 2003

South African approval to begin phase I trial of HIVA.MVA

Aug. 28, 2003

Antiviral and spermicidal agent WHI-05 in development

Aug. 27, 2003

Takeda develops new fusion inhibitors for AIDS therapy

Aug. 20, 2003

Gilead begins enrollment in phase III Viread combination trial

Aug. 19, 2003

AIDS Healthcare Foundation to urge FDA to withdraw Trizivir approval

Aug. 18, 2003

Japan Tobacco to commercialize Gilead HIV products in Japan

Aug. 5, 2003

New HIV protease inhibitors prepared and tested at Tibotec-Virco

Aug. 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...